Management of solid renal tumour associated with von Hippel-Lindau disease

Chinese Medical Journal

Volumn 120, Issue 22, 2007, Pages 2049-2052

  Zhang, Jin ^a   Huang, Yi Ran ^a   Liu, Dong Ming ^a   Zhou, Li Xin ^a   Xue, Wei ^a   Chen, Qi ^a   Dong, Bai Jun ^a   Pan, Jia Hua ^a   Xuan, Han Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Germ line mutation; Hippel Lindau disease; Nephron sparing surgery; Renal cell carcinoma

Indexed keywords

CREATININE;

ADULT; ARTICLE; BONE METASTASIS; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY DISEASE; KIDNEY TUMOR; LYMPH NODE METASTASIS; MALE; NEPHRECTOMY; NEPHRON SPARING SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RECURRENT DISEASE; SOLID TUMOR; SURGICAL TECHNIQUE; URINE INCONTINENCE; VON HIPPEL LINDAU DISEASE;

EID: 36949038459     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200711020-00022     Document Type: Article

References (11)

1. Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998; 12: 417-423.
2. Lamiell JM, Salazar FG, Hsia YE. Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore) 1989; 68: 1-29.
3. Huang YR, Zhang J, Wang JD, Fan XD. Genetic study of a large Chinese kindred with von Hippel-Lindau disease. Chin Med J 2004; 117: 552-557.
4. Ashida S, Furihata M, Tanimura. M, Sugita O, Yamashita M, Miura T, et al. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status. J Urol 2003; 169: 2089-2093.
5. Neumann HP, Zbar B. Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int 1997; 51: 16-26.
6. Hes FJ, Lips CJ, van der Luijt RB. Molecular genetic aspects of von Hippel-Lindau disease and criteria for DNA analysis in subject at risk. Neth J Med 2001; 59: 235-243.
7. Grubb RL 3 rd, Choyke PL, Pinto PA, Linehan WM, Walther MM. Management of von Hippel-Lindau associated kidney cancer. Nat Clin Pract Urol 2005; 2: 248-255.
8. Steinbach F, Novick AC, Zincke H, Miller DP, Williams RD, Lund G, et al. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol 1995; 153: 1812-1816.
9. Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL, Walther MM. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 2001; 165: 777-781.
10. Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, et al. The relationship between renal tumor size and metatases in patients with von Hippel-Lindau disease. J Urol 2004; 172: 63-65.
11. Carini M, Minervini A, Lapini A, Masieri L, Serni S. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival. J Urol 2006; 175: 2022-2026.